PV pharm branch, vendor, cage 0U9U0
Ended Awarded
- Contract number
- SPE2D826F04TQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $146,938
Award facts
- Contract value 100% obligated
- $146,938.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $146,938.40 by the Defense Logistics Agency's Medical Supply Chain on November 5, 2025, with an ultimate completion date of November 6, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
Under this delivery order and its parent contract, AmerisourceBergen supplies critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The award demonstrates AmerisourceBergen's capability to meet federal procurement requirements through open competition and reflects the company's significant role as a pharmaceutical prime vendor for military and veteran healthcare systems. The DLA's Pharmaceutical Prime Vendor Global Program intends to establish Generation V contracts with multiple regional awards, positioning AmerisourceBergen as one of the strategic contractors supporting the department's medical supply chain operations.
Quick answers
Who was awarded contract SPE2D826F04TQ?
SPE2D826F04TQ was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on November 5, 2025.
How much is contract SPE2D826F04TQ worth?
The government has obligated $146,938 on SPE2D826F04TQ.
Is contract SPE2D826F04TQ an order under another contract?
Yes. SPE2D826F04TQ is a delivery order under SPE2DX22D0029, an indefinite delivery contract.
Was contract SPE2D826F04TQ competed?
The extent of competition for SPE2D826F04TQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award